7:12 am Synthetic Biologics announces issuance of U.S. patent adding another layer of protection for the use of oral estriol candidate, Trimesta, for multiple sclerosis – HedgeChatter

7:12 am Synthetic Biologics announces issuance of U.S. patent adding another layer of protection for the use of oral estriol candidate, Trimesta, for multiple sclerosis

11 Mar

7:12 am Synthetic Biologics announces issuance of U.S. patent adding another layer of protection for the use of oral estriol candidate, Trimesta, for multiple sclerosis

Bystocknews stock, SYN Comments Off

View todays social media effects on SYN

View the latest stocks trending across Twitter. Click to view dashboard

See who Synthetic is hiring next, click here to view

Author